Friday, Mar 29 2024 | Time 19:32 Hrs(IST)
image
Parliament


Maximum Covid-19 cases reported in 13 states:Dr Harsh Vardhan

Maximum Covid-19 cases reported in 13 states:Dr Harsh Vardhan

New Delhi, Sep 15 (UNI) Union Health and Family Welfare Minister Dr Harsh Vardhan on Tuesday informed the Rajya Sabha that at present maximum COVID-19 cases and deaths are being reported from Maharashtra, Andhra Pradesh, Tamil Nadu, Karnataka, Uttar Pradesh, Delhi, West Bengal, Bihar, Telangana, Odisha, Assam , Kerala and Gujarat.
While making a statement in the Upper House, he said, “As on September 11, a total of about 40 lakh persons have been kept under surveillance and extensive contact tracing of all positive cases and it has been regularly being undertaken through disease surveillance network so as to break the chain of transmission.
In our country, about 92 per cent of the cases have been reported to be having mild disease and in only about 5.8 per cent of cases, the oxygen therapy is required whereas only 1.7 per cent of cases need intensive care, he added.

The Heath Minister further said that as on September 12, a total of 15,284 treatment facilities, with 13,14,646 dedicated isolation beds without oxygen support had been created. Also, a total of 2,31,093 oxygen-supported isolation beds and 62,717 ICU beds (including 32,575 ventilator beds) had been created, besides 12,826 quarantine centres with 5,98,811 beds have been set up.
On repurposed drug use in COVID-19, the Minister said that 13 clinical trials of repurposed drugs and harnessing of traditional knowledge using the modern medicine approach were building a portfolio of therapeutic options for COVID-19 patients.
“Phase 2 clinical trial of immune modulator Sepsivac has been completed successfully. Phase 2 clinical trial of the first-ever phytopharmaceutical ACQH is underway. One prophylactic trial of Aswagandha and three trials of Guduchi + Pippali; Yashtimadhu; and polyherbal AYUSH drug (AYUSH-64) are planned on moderately ill COVID-19 patients,’’ he said.
Referring to around 145 candidate vaccines across the world, the Minister said that these have been under in pre-clinical evaluation whereas 35 vaccines in the stage of clinical trials.
“In India, the major focus has been on facilitating the development of COVID-19 vaccine. More than 30 vaccine candidates have been supported and they have been in different stages of development while three candidates in advanced stage of Phase I/II/III trials and more than four are in the advanced preclinical development stage,’’ he noted.
UNI AKS SB 1358

There is no row at position 0.
image